Objective: Liver stiffness (LS) values are known to be associated with increased right ventricle (RV) pressure in patients with heart failure (HF). The aim of this study was to determine the changes in LS in patients of different New York Heart Association (NYHA) classes and the parameters related to increased LS in HF patients with reduced ejection fraction (HFrEF).
H eart failure with reduced ejection fraction (HFrEF) is a disease with a poor prognosis. It is defined as having a left ventricular (LV) ejection fraction (EF) of <40% in the latest heart failure (HF) guideline. [1] Anamnesis, physical examination, posteroanterior chest X-ray, electrocardiography, echocardiography, and biochemical parameters, including natriuretic peptide (NT-proBNP), are used in the follow-up and treatment of patients with HF. [1] All of the congestive findings that occur in patients with HF are subjective; an objective parameter is needed to determine congestion. Liver function test measurements of bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gammaglutamyl transpeptidase (GGT) are recommended as routine examinations.
In patients with HF, liver disease occurs in the advanced classes due to liver congestion and is known as cardiac hepatopathy. [2] This condition is associated with increased central venous pressure (CVP) and worsening in liver function tests, and is an indicator of poor prognosis. [3] [4] [5] [6] [7] The causes of congestive cardiac hepatopathy are isolated right ventricular (RV) failure, biventricular failure, pulmonary arterial hypertension (HT), severe tricuspid regurgitation, constrictive pericarditis, and congestive HF. [8] In congestive cardiac hepatopathy patients, CVP, filling pressure, and RV diastolic pressure are increased. [9] The liver is surrounded by a membrane and increased liver congestion leads to an increase in LS. Liver elastography (LE) is a newly developed ultrasound (US) technique that can quantitatively and noninvasively measure liver tissue stiffness and the development of fibrosis. Congestion in the liver due to HF causes hepatomegaly and right upper quadrant pain. This congestion occurs due to the fact that the liver, which has a hard capsule, is not elastic, and increases the stiffness of the tissue. [10] Therefore, a liver stiffness (LS) value obtained with LE in HF patients can be used to assess liver congestion and increased right atrium (RA) pressure. [11] Considering this physiopathology, especially in studies conducted in the last year, the LS measurements obtained with LE have been shown to be associated with RV pressure, poor prognosis, and decreased functional capacity in different HF etiologies. [10] [11] [12] [13] [14] An LS value can be obtained for almost all patients and provide a more objective measurement with the recently developed acoustic radiation force impulse or ElastPQ (Philips Healthcare, Inc., Andover, MA, USA) techniques. [15, 16] One of the most important goals in the treatment of HF is the correction of RV and LV systolic functions and functional capacity. These 2 parameters are the most important prognostic indicators for HF. The relevance of LS to these parameters has been assessed in different groups of patients in various studies. [10] [11] [12] [13] [14] 17, 18] However, changes in the LS value in HFrEF in each New York Heart Association (NYHA) class, and the clinical and laboratory HF parameters associated with LS are still unclear. It was hypothesized that this increased pressure physiopathology due to increased volume and increased LS value may be closely related to NYHA class and LV and RV functions in HFrEF patients.
The objective of this research was to determine the LS change according to NYHA class and the LS-related parameters observed in HFrEF patients.
METHODS

Study population
This study included 181 patients who were referred to the cardiology clinic (111 males, 70 females; mean age: 64.3±9.1 years) with HFrEF (EF ≤40%) and receiving medical treatment according to HF stage. All of the patients included in the study had chronic HF. , presence of hepatitis B or C, regular alcohol use (>20 g/day) or alcohol addiction, severe valvular heart disease, portal HT, inflammatory disease, hematological disease, active thyroid disease, cancer, and/or suspected pregnancy, and patients who declined to participate were excluded. The study was conducted according to the recommendations of the Declaration of Helsinki regarding biomedical research involving human subjects and the protocol was approved by the institutional ethics committee (Approval date: 28-Feb-2018, Approval number: 12-171). The study was explained to the patients in detail and written consent was provided by the participants. A detailed anamnesis was obtained from all of the patients and a detailed physical examination was performed. Subsequently, the baseline characteristics of all of the groups were recorded: age, gender, active smoking, and the presence of ischemic etiology for HF, HT, diabetes mellitus, atrial fibrillation (AF), or hyperlipidemia. The patients' pulse rate, systolic blood pressure, and diastolic blood pressure were recorded. Body mass index was calculated by measuring weight and height. The eGFR was calculated using the Modification of Diet in Renal Disease Study Group formula 3: eGFR (mL/ min/1.73 m 2 ) = 186 × (serum creatinine) -1.154 × (age) -0.203 (0.742 for female patients). [19] 
Echocardiographic evaluation
Echocardiography examinations were performed using the EPIQ 7 device (Philips Healthcare, Inc., Andover MA, USA). Images were taken according to the guidelines of the American Echocardiography Society. Standard parasternal long and short axis view images were obtained, as well as in the apical 5 th , 4 th , and 2 nd space windows for at least 3 consecutive cycles while the patient was in the left lateral decubitus position. [20] Parasternal long-axis M-mode examination revealed LV diastolic and systolic dimensions (LVd and LVs) and left atrial diastolic (LAd) dimensions. The LVEF was calculated using the modified Simpson method from the apical 4 th and 2 nd space windows.
[21] Tricuspid regurgitation pressure gradient (TRPG) was calculated using the Bernoulli equation over the peak flow rate of tricuspid regurgitation. RV diastolic diameter and tricuspid annular plane systolic excursion (TAPSE) were measured from a RV focused apical 4-chamber view. RV isovolumetric contraction time (ICT), isovolumetric relaxation time (IRT), and ejection time (ET) were measured 5 times with pulse wave Doppler to obtain the RV-myocardial performance index (MPI) value. RV-MPI was calculated with the formula of (ICT + IRT) / ET after the mean values of 5 measurements were obtained. [22] Biochemical parameters Blood samples were taken from an antecubital vein after the patients had rested for 20 minutes in the supine position. Blood samples were collected in tubes containing ethylenediaminetetraacetic acid. A complete blood count was performed. The samples were spun at 3000 rpm for 10 minutes at 0°C. Upon study inclusion, blood urea nitrogen, creatinine, total cholesterol, high--density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglycerides were measured using standard automated laboratory methods (Aeroset; Abbott Laboratories, Lake Bluff, IL, USA) with the appropriate commercial kits. Serum albumin, AST, ALT, GGT, direct bilirubin, uric acid, high-sensitivity C-reactive protein, and NT-proBNP levels were also measured using the Abbott Aeroset automated chemistry analyzer with the appropriate commercial kits.
Liver ultrasound
All of the patients underwent liver US screening using the EPIQ 7 high resolution US device and a 1-5 MHz high-resolution convex probe (Philips Healthcare, Inc., Andover MA, USA). The liver US was performed after a minimum fasting period of 8 hours initially using B-mode gray scale imaging to assess the diameter of the inferior vena cava (IVC) on the long axis and measured within 3 cm of the IVC-RA junction during passive respiration. LS measurements were performed using the ElastPQ technique, which is a point shear wave elastography assessment, with the patient in the lateral decubitus position. During hepatic US, the least possible compression was applied with the probe, which was maintained in a constant position, to avoid mechanical pressure on the liver. During the procedure, the participants were asked to pause breathing for a few seconds to minimize hepatic movement occurring In univariate analyses, logistic regression analysis was performed to determine the independent markers among patients with an LS >7 kpa and >10.6 kPa. Parameters associated with LS were determined using univariate with respiration. After traditional hepatic US images were obtained, the target area was determined and the measurements were performed after the range of imaging (ROI) was positioned on the target (Figs. 1a-d). The ROI was positioned perpendicular to an area containing no vascular structures or space-occupying lesions. The maximum ROI target distance was 8 cm in this study, with a constant ROI box dimension of 1 cm-0.5 cm. In each patient, 10 valid measurements from different hepatic parenchymal segments were obtained and the average was calculated. The results were expressed in terms of kPa; when the reliability of the measurement was low, the image would have a kPa of 0.00. The study participants were stratified into 2 groups: those with or without liver failure (LF), based on the liver stiffness measurement (LSm). Using the cut-off values reported in 4 important recent studies, the threshold values adopted for mild and severely increased LSm to determine the presence of HF were >7 kPa and >10.6 kPa. [11] [12] [13] [14] Pearson's and Spearman's correlation analyses. Statistically significant parameters were included in a linear regression analysis, and the parameters with the closest association to LS were identified. ROC curve analysis was performed for LS values to determine the patients with class III-IV HF. From these analyses, limit value determination was conducted to ascertain the best sensitivity and specificity in the determination presence of class III-IV HF. A p level of <0.05 was considered statistically significant.
RESULTS
The mean, median, and minimum and maximum LSm values in HFrEF patients were 7.77±3.07 kPa, 7.20 kPa, and 3.50 kPa and 18.7 kPa, respectively. Successful LS measurements were obtained from all of the patients in the study. The study data were divided into 4 groups according to NYHA class: class I, II, III, and IV patients. In addition, parameters that independently determined the patients with LS values >7 kPa and >10.6 kPa were determined.
Demographic, clinical, and laboratory data according to NYHA class
When the demographic data were compared according to the patients' NYHA class, age, and gender were found to be similar in all NYHA class groups. It was determined that while the presence of AF increased with NYHA class, other demographic and clinical parameters were similar ( Table 1 ). The presence of pretibial edema, hepatomegaly, and hepatojugular reflux were higher in NYHA class III-IV patients. NT-proBNP, ALP, and GGT levels were significantly higher with an increasing level of NYHA classification, and were highest in the NYHA class IV patient group (Table 1) . The eGFR value, serum albumin, total cholesterol, and triglyceride levels were significantly lower with each increase in NYHA class, and the values measured were lowest in the NYHA class IV patient group. Other laboratory data were similar in all NYHA classes.
Echocardiography data according to NYHA class
When the echocardiographic parameters of the patients were compared according to NYHA class, it was observed that the LVd and LVs diameters were greater with an increasing NYHA class, and were highest in the NYHA class IV patient group (Table 2) . LVEF values decreased with a higher NYHA classification, and were lowest in the NYHA class IV patient group (Table 2) . RVd and LAd diameters, and TRPG and RV-MPI values were significantly different between class groups, increased with NYHA classification, and were highest in the NYHA class IV group (Table 2 ). TAPSE was similarly significantly different between classes, but decreased with a higher NYHA class, and was found to be lowest in the NYHA class IV patient group (Table 2) .
Liver ultrasonography data according to NYHA class
In a comparison of liver US findings according to NYHA class, the LS values and the inspiration and expiration IVC diameters were determined to be significantly different between class groups, increasing with the NYHA class, and were highest in the NYHA class IV patient group (Table 2 and Fig. 2 ). Similarly, a measurement of LS >7 kPa or >10.6 kPa increased with NYHA classification and was found to be highest in the NYHA class IV patient group (Table 2) .
Relationship between NYHA class III-IV and liver stiffness
When patients with HFrEF were separated into advanced class HF (NYHA class III-IV) and non-advanced class HF (NYHA class I-II), the LS values measured by LE were found to be 5.85±1.98kPa and 9.59±2.82 kPa, respectively (p<0.001). Logistic regression analysis revealed that LS independently determined the presence of having class III-IV disease (odds ratio eGFR: Estimated glomerular filtration rate; NYHA: New York Heart Association. α = the significant association between the NYHA I group and the NYHA IV group (p<0.05); β = the significant association between the NYHA I group and the NYHA III group (p<0.05); * = the significant association between the NYHA I group and the NYHA II group (p<0.05); ¥ = the significant association between the NYHA II group and the NYHA IV group (p<0.05); µ = the significant association between the NYHA II group and the NYHA III group (p<0.05); ** = the significant association between the NYHA III group and the NYHA IV group (p<0.05).
graphic, and US parameters associated with LS in the univariate analysis are summarized in Table 3 . Linear regression analysis was performed with the parameters significantly related to LS (Table 3) . LS values were found to be closely related to TRPG, RV-MPI, TAPSE, and NT-proBNP levels (Table 3 , Fig. 4a-d ).
creased the risk of being class III-IV by 94.4%. A similar analysis was performed with a ROC curve and found that the area under the ROC curve was 0.878 (95% CI 0.825-930; p<0.001; Fig. 3 ). The analysis indicated that when the cut-off value for LS was 7 kPa, patients with class III-IV disease could be determined with 82.8% sensitivity and 81.8% specificity.
The parameters associated with liver stiffness measurements
The demographic, clinical, laboratory, echocardio- and US parameters associated with slightly elevated LS in univariate analysis. TAPSE, AST, and LAd were independently associated with patients with LS >7 kPa ( Table 4 ). The same analyses were performed to identify patients with greater LS. RV-MPI, NT-proBNP, and ALT levels were indepen-
Parameters associated with mild and severely increased liver stiffness values (>7 kPa and >10.6 kPa)
Increased LS was defined as >7 kPa. Multivariate logistic regression analysis was performed with demographic, clinical, laboratory, echocardiographic, RV systolic function parameters of TAPSE and RV-MPI. Another important finding was that, as shown in previous HF studies, there was a close association between LS and NT-proBNP, AST, and ALT values calculated in the liver function tests of HFrEF patients. Our study differs from previous studies in terms of using a new LE method, ElastPQ, in isolated HFrEF patients.
LS measurement obtained by LE is primarily used in hepatology clinics and is closely related to LF. [23, 24] With evolving technology and LE methods, as well as greater accessibility to US devices, LS measurement dently associated with patients with LS >10.6 kPa (Table 4) .
DISCUSSION
This study has 3 main findings. The first of these was that the LS value was significantly greater with a higher NYHA classification in HFrEF patients and independently determined the presence of NYHA class III-IV HF. A measurement of >7 kPa was an important LS threshold value in HF, and it also objectively determined patients with advanced class HF. Secondly, LS in patients with HFrEF was closely related to the limit value used was ≥7 kPa. [13, 14] In another study conducted by Taniguchi et al., [13] the average kPa value was reported to be 5.6 kPa, but when the patients were divided into 3 groups, ≥7 kPa was used to define the high limit for HF severity, increased rightside filling pressure, and poor prognosis. Patients in our study were not divided into 2 or 3 groups according to kPa values as in previous studies for data analysis. Isolated HFrEF and ElastPQ methods were used for the first time in this study and we elected not to use the limit values obtained from previous studies. We found increased LS (LS >7 kPa) in our study at a rate of 13%, 26%, 72%, and 91% in NYHA class I, II, III and IV patients, respectively. In another study by Taniguchi et al., [11] the authors reported that there was a close relationship between invasively measured RAP and LS obtained with TE. The LS value has been reported to better detect elevated RAP (>10 mm Hg) with a vena cava inferior diameter >21 mm and/or <50% reduction in the diameter with inspiration. [11] In the same study, it was reported that when the LS limit value was 10.6 kPa, it was useful to determine the presence of RAP >10 mm Hg with 85% sensitivity and 93% specificity. [11] However, in this invasive study, HF patients with all EF values were included. LS was observed in patients of NYHA class I, II, III, and IV at a rate of 3%, 9%, 26%, and 57%, respectively, when LS ≥10.6 kPa was used, a level determined in previous studies to identify patients with severe RAP elevation (>10 mm Hg). [11] This result in our study is a separate proposition in terms of results obtained from only patients with HFrEF and using the ElastPQ method.
The increase in LS that occurs in patients with HF is mainly related to clinical, biochemical, and echocardiographic parameters in HF patients. [11, 13] Research has revealed that increased liver congestion leads to an increase in cholestasis parameters (AST, ALT, GGT, total protein), [5, 11, 12, [28] [29] [30] as well as a decrease in parameters showing synthesis in liver, such as cholesterol and albumin [11, 12, [31] [32] [33] in HF patients. Taniguchi et al. [11] found that increased total bilirubin, GGT, and ALP levels were closely related to LS in patients with HF. In this important study, no significant results were obtained in the regression analysis due to a small study population. In our study, there was a close and independent relationship between NTproBNP, AST, and ALT levels and LS. has become feasible for HF patients. Our research revealed that a number of important studies, mostly in 2018, have been conducted on LE evaluation in HF patients without chronic liver disease, and an increase in LS has been reported. [10] [11] [12] [13] [14] 17, 18] As a result of these studies, the conclusion has been reached that LS can be used in the follow-up and treatment of HF patients without chronic liver disease. A study of LS measurement for HF patients was first conducted by Millonig et al. [10] on animal subjects and was reported to be closely related to an increase in central venous pressure. In the evaluation of congestive cardiac hepatopathy since 2010, an LS assessment obtained with LE has critical importance and provides clearer and more objective information. The objective relationship between LS and right atrial pressure (RAP) was clearly shown in an invasive and objective study involving only a small number of patients. [11] The initial LS examination technique was transient elastography [11] [12] [13] and developed into shear wave elastography (SWE), [24] and point SWE. [18] All of these studies have demonstrated a greater LS value in HF patients. It has been shown that there is very close correlation between the LS value and right-sided filling pressure in LE studies. [10] [11] [12] [13] Taniguchi et al. [11] investigated the correlation between LS obtained with TE and RAP (mmHg) and reported a calculation of -5.8 + 6.1 x ln [LS (kPa)]. We did not use this formula because new kPa values were obtained with new model devices. In addition, a FibroScan device (Echosens SAS, Paris, France) was used in this invasive study and the probability of successful measurement was reported to be <60%. [11] In our study, we used a high-end US device and the ElastPQ technique, described in one of the point SWE studies using state-of-the-art technology. The LS value was successfully obtained for all patients. The most important feature of the ElastPQ technique used in the present study, along with the different LE measurement methods, is ease of use, a high rate of measurement possibility, and high power to predict liver pathology. [15, 16] Different limit values have been used to define increased LS as a result of different devices, methods, and groups of patients (HFrEF or HFpEF). Ten measurements are made in each case and the average is reported in units of kPa as an LS value. In acute decompensated HF patients, LS was high and the increased LS limit value has been defined as 8.8 kPa. [12, 26, 27] In 2 recent studies and in some previous studies, the LF was determined that when the cut-off value for LS was 7 kPa, the presence of advanced HF was determined independently. Similar to this finding of our study, 2 studies by Taniguchi et al. [11, 13] reported a close association between the LS value and the severity of HF. However, in these studies, no regression analysis was performed and the patients were in different HF etiologies. [11, 13] In another important study evaluating the association between acute HF and LS, there was no close association between LS value and NYHA class. [12] Our results indicated that the LS value independently determined the NYHA functional class. It was found that LS independently determined the presence of class III-IV and that the increase of 1 kPa increased the risk of being class III-IV by 94.4%. Earlier studies have demonstrated a positive and close relationship between LS value and NYHA class, but this relationship was not independent. In our study, it was also found in the multivariate analysis that the LS value and the NYHA class were independently correlated. We also found that LS independently detected patients with class III-IV HF with advanced class HF for the first time. In HFrEF patients; the median kPa values in patients with NYHA class I, II, III, and IV were observed for the first time as 5.25±1.51 kPa, 6.39±2.15 kPa, 8.50±2.14 kPa and 10.7±3.10 kPa, respectively.
Study limitations
One of the most important limitations of this study is that our study data were not confirmed with a liver biopsy. A liver biopsy and magnetic resonance imaging (MRI) were not performed due to the invasive nature and expense. If this additional research data were available, more objective results could be obtained. However, performing a liver biopsy in patients with HF would be unethical. Based on the results of previous studies, only patients with HF were included and these patients were compared according to their NYHA class. If a healthy control group without active HF were included, different results might be obtained. All of the patients in this study were receiving optimal treatment according to their clinical findings and NYHA class. For this reason, the effect of the current treatment on LS was not evaluated. Medical, and in some diseases, surgical treatment, has been shown to decrease LS. [17, 25, 36] There is a very close relationship between invasively measured RAP and LS. [11] The LS value may have been even more significant if our present findings included RAP measurements. Pa-TAPSE measurement from echocardiographic parameters is an important parameter for reduced TV function. A recent study by Saito et al. [12] found a close and negative relationship between TAPSE and LS. Similar results were supported by another recent study. [13] However, the close relationship between TAPSE and LS obtained in both studies was not seen between LS and LVEF. [12, 13] The most important reason is that there are different HF groups according to EF. Our study also found that LS was independently associated with RV function parameters TAPSE and RV-MPI, consistent with previous studies. In addition, in our study, although there was a relationship between LVEF and LS values in univariate analysis, there was no independent relationship between LS values and LVEF, also consistent with previous studies. Among the other echocardiographic parameters, LAd diameter and TRPG were closely and independently related to LS. The most important difference between our study and previous studies is that the data in our study was obtained from HFrEF patients with only one type of HF. Echocardiography is still an important study in HF diagnosis and follow-up. The LS value obtained by simple measurement with LE can be a helpful review, especially to illustrate if RV functions have been affected.
NT-proBNP is an important and objective laboratory parameter used for diagnosis, follow-up, treatment and prognosis in HF patients. [1, 34, 35] One of the non-cardiac causes of NT-proBNP increase is liver dysfunction. Studies have shown a close relationship between NT-proBNP and LS. [13] In our study, the NTproBNP level was found to independently determine patients with LS >7 kPa.
HF is a major problem in the modern world. The most important problem in HF patients is a poor prognosis and impaired quality of life. It is very important that patients with HF are well classified according to the NYHA system and that patients with low functional capacity are identified. It is important to obtain objective parameters for functional capacity determination. Previous studies have reported that NTproBNP, low EF, and large heart cavities are associated with decreased functional capacity. [1, 34, 35] However, in patients with isolated HFrEF, the relationship between NYHA functional class and LS is not clear, and there is no information about LS values in the NYHA classification system. ROC analysis was performed to determine class III-IV patients with advanced HF, and it tients with severely kidney and liver failure were not included in the study. These conditions are common in HF patients; however, our data cannot be used for this patient group. Because of the patient selection of isolated HFrEF and the use of the ElastPQ technique, no limit value comparison can be made with another study. LS measurement in HF patients is also both a congestion parameter and a prognosis parameter, but our patients were not followed in terms of prognosis. MRI is a noninvasive modality to detect LS; however, MRI is an expensive imaging method with limited availability. [37] On the other hand, liver US is a noninvasive, inexpensive, and widely available imaging modality that can be used for the same purpose.
Conclusion
An increased LS value in patients with HFrEF is closely related to the progression of NYHA classification, and it's closely and independently related to liver function tests, NT-proBNP, RV systolic function and pressure, and determines advanced class HF presence. LS measurement obtained by LE is a noninvasive, reproducible, objective, inexpensive US study that can be performed in as little as <5 minutes, and can be used in HF cases. As in patients with HF with acute and variable etiology, having HFrEF also increases the LS value, which can be used in the clinical followup of patients with measured LS values. Patients with LS >7 kPa should be closely followed and treated. LS measured by LE in HF patients may be added in the coming years as a routine follow-up parameter to the recommended liver function tests routinely performed by the guidelines; however, we concluded that our results should be strengthened by new studies of patients with different and more HF patients, possibly in multicenter studies. 
